NOSA microbial control
7,0 €
NOSA microbial control is designed to reduce the exposure of viruses and bacteria by inhalation through the nose. A reduced exposure of viruses and bacteria reduces the risk of respiratory infections. The product is easy to breathe through, discreet and comfortable to wear.
NOSA microbial control is a medical device class I and is available in Europe. External lab tests have shown that NOSA microbial control can reduce up to 93% of Coronavirus, Rhinovirus and Norovirus as well as 99% of Staphylococci (MRSA), Pneumococci and E-coli when in contact with the device.
Reduces the exposure of viruses and bacteria
up to 93% viral reduction:
Coronavirus
Norovirus
Rhinovirus
up to 99% bacterial reduction:
Staphylococcus (MRSA)
Pneumococci
E-coli
Learn more
The product design forces the air to pass through the lamella structure of the device where it inactivates viruses and kills bacteria that get in contact with the product. This is made possible due to the silver phosphate particles infused into the material.
Inside the nose is a sensitive area called the mucous membrane. Viruses and bacteria can enter the body and infect humans through this area. A reduced exposure to viruses and bacteria in the nose has been shown to reduce the risk of respiratory infections. NOSA microbial control is tested against many of the most common flu viruses.
The latest research shows that there are two types of cells inside the nose that are the likely entry point for COVID-19. These cells work as “viral entry receptors” and are highly accessible to the corona virus because of the location in the nose.¹
Years of product development resulted in a patented design that:
Reduces viruses
Reduces bacteria
Is easy to breathe through
Is discreet and comfortable
Has an innovative design
Can be used for up to 8 hours
Not sure how to place NOSA microbial control in your nose correctly?
Watch the instruction video here!Hold the product bracket between your index fingers and thumbs and carefully place the product in your nostrils until the bracket meets the nasal wall.
Carefully press the product upwards with your index finger and thumb until it is placed correctly and does not fall out.
If you feel that the product is placed wrong, try to adjust the product again until it feels comfortable. Do not use if any discomfort arises.
The corona virus is one of the most common flu viruses right now, together with rhinovirus, norovirus and adenovirus among others. The variants associated with COVID-19, for example “Delta” and “Omicron” are mutations of the coronavirus and it is known that mutations can be more contagious to humans than previous variants. There is much to suggest that the new mutations of the coronavirus in the future will be part of the recurring pool of viruses.²
There are two types of cells in the nose that the coronavirus primarily attacks to infect the body. These cells work as “viral entry receptors” and are highly accessible to the corona virus because of the location in the nose.¹
Tests performed by external laboratories show that NOSA microbial control can reduce Coronavirus, Rhinovirus and Norovirus up to 93% and Staphylococci (MRSA), Pneumococci and E-coli up to 99%.
The face mask most commonly used, the surgical mask, aims to reduce the transmission of infectious particles from the user to the environment through exhalation.³
In other words, it aims to protect others from your potential infectious particles. The only respiratory protection intended to protect the user against viruses and bacteria is FFP3, the highest class of filters, which is often used within the chemical industry.⁴
NOSA microbial control is designed to reduce the user’s exposure of viruses and bacteria by inhalation through the nose. A reduced exposure of viruses and bacteria reduces the risk of respiratory infections.
The device has been tested against some of the most common viruses and bacteria, such as Coronavirus, Rhinovirus and Norovirus as well as Staphylococcus including MRSA, pneumococci and E-coli.
Yes, you can explore all our Distributors for NOSA microbial control on the distributors page.
¹ Sungnak et al, SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes, Nature Medicin 26, s.681–687 (2020)
² folkhälsomyndigheten, 2022
³ Läkemedelsverket, 2021
⁴ Europeiska Kommissionen, 2022
Add a review
Be the first to review “NOSA microbial control”
Related products
-
NOSA odor control
7,0 €
There are no reviews yet.